ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

摘要:

An international faculty of cardiologists reviewed the latest preventative, diagnostic and therapeutic evidence in coronary artery disease (CAD) at the first Recent Advances in Cardiology International Meeting held recently in Sardinia.*CAD remains one of the major causes of death in the developed world. While diagnostic and surgical procedures are progressing rapidly, drug therapy represents the major advance of recent years. The results of large clinical trials and a growing understanding of the pathophysiology of CAD suggest that lipid-lowering therapy with HMG CoA reductase inhibitors [statins] will make a major contribution to the management of the disease. In addition, the calcium antagonist amlodipine appears to have atheroprotective effects, which translate into a substantial reduction in cardiovascular events.

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

摘要:

Levetiracetam is a piracetam analogue which was originally intended as a nootropic. However, thanks to serendipity, the drug is now a promising new option for the treatment of epilepsy. It is currently at the final stage of the drug development process and has been filed for approval in both the US and Europe. Although not yet licensed, levetiracetam has aroused plenty of interest and at the 23rd International Epilepsy Congress [Prague, Czech Republic; September 1999] it was discussed in detail.

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1999

数据来源: ADIS